Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)

Funding Agency:
National Institutes of Health

The Office of Research on Women’s Health (ORWH) announces the availability of administrative supplements to support research highlighting health inequities among women in the United States who are understudied, underrepresented and underreported (U3) in biomedical research.

This notice will support projects investigating inequities in women and girls’ health and intervention studies to improve equity. Additionally, projects with an emphasis on those that integrate measures beyond the individual level and consider perspectives from multiple disciplines are of specific interest. A broad range of research topics studied at the preclinical, clinical, behavioral, and translational levels—including proposals incorporating multilevel interventions, using community-engaged approaches, and focusing on one or more NIH-designated health disparities populations—are encouraged.

Deadline: Jan. 31, 2024


Agency Website

Eligibility Requirements

  • Only PDs/PIs of an active DP1, DP2, DP4, DP5, K01, K08, K23, K76, K99/R00, P01, P20, P30, P40, P41, P50, P51, P60, P2C, PM1, R01, R03, R15, R21, R24, R25, R33, R34, R35, R37, R41/R42, R43/R44, R41, R42, R43, R44, R61, RF1, RC4, RM1, S06, S11, U01, U10, U19, U2C, U24, U42, U44, U54, U56, UC2, UL1, UM1, UM2, UG1, UG3/UH3, UH2/UH3, UH2, or UP5 award from NIH are eligible to apply.

Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

January 31, 2024